SCHEMBL15079428

SCHEMBL15079428

O=C(COc1ccc(Oc2ccccc2)cc1)c1ccccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNLIP P16233 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
ALOX15 P16050 2/20 0.50
RAB9A P51151 3/20 0.49
MAPT P10636 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HPGD P15428 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48
HTT P42858 1/20 0.48
NPC1 O15118 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
POLB P06746 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7104094 0.93 ALOX15 (0.57) SMN1; SMN2ALOX15RAB9AMAPTNPSR1
SCHEMBL15079897 0.87 MAPT (0.57) SMN1; SMN2ALOX15RAB9AMAPTNPSR1
SCHEMBL15079772 0.86 PKM (0.56) SMN1; SMN2RAB9AMAPTNPSR1HPGD
SCHEMBL15079898 0.84 NPC1 (0.66) PNLIPSMN1; SMN2ALOX15RAB9AMAPT
SCHEMBL15079381 0.84 RAB9A (0.68) PNLIPSMN1; SMN2RAB9AMAPTNPSR1
SCHEMBL15079411 0.84 KMT2A (0.62) SMN1; SMN2ALOX15RAB9AMAPTNPSR1
SCHEMBL15079875 0.84 KMT2A (0.65) SMN1; SMN2RAB9AMAPTNPSR1HPGD
SCHEMBL15079915 0.84 KMT2A (0.59) PNLIPSMN1; SMN2RAB9AMAPTNPSR1
SCHEMBL15079421 0.83 RAB9A (0.46) SMN1; SMN2ALOX15RAB9AMAPTNPSR1
SCHEMBL15079369 0.81 KDM4E (0.52) SMN1; SMN2RAB9AMAPTNPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
WO-2013093320-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS ARG1, TYR, NOS1 PNLIP 2701/4885SMN1; SMN2 2350/4885ALOX15 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.